Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-26T00:31:10.050Z Has data issue: false hasContentIssue false

Methylphenidate Treatment in ADHD/borderline Personality Disorder Adolescent Girls and Smoking Behavior

Published online by Cambridge University Press:  16 April 2020

P. Golubchik
Affiliation:
Geha Mental Health Center, Beilinson Campus, Tel-Aviv University, Petah Tiqwa, Israel
J. Sever
Affiliation:
Geha Mental Health Center, Beilinson Campus, Tel-Aviv University, Petah Tiqwa, Israel
G. Shoval
Affiliation:
Geha Mental Health Center, Beilinson Campus, Tel-Aviv University, Petah Tiqwa, Israel
G. Zalsman
Affiliation:
Geha Mental Health Center, Beilinson Campus, Tel-Aviv University, Petah Tiqwa, Israel
A. Weizman
Affiliation:
Geha Mental Health Center, 5 Felsenstein Medical Research Center, Beilinson Campus, Tel-Aviv University, Petah Tiqwa, Israel

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Cigarette smoking and nicotine dependence is prevalent among the attention deficit/hyperactivity disorder (ADHD) pediatric population. We assessed the influence of methylphenidate treatment on the smoking behavior of adolescent girls with ADHD/ borderline personality disorder (BPD).

Method:

Twelve ADHD/BPD female adolescent smokers aged 14-19 years were treated with MPH for an 8 week period. The severity of ADHD was assessed by the ADHD Rating Scale (ADHD-RS) and the smoking behavior was rated by Fagerstorm Test for Nicotine Dependence (FTND).

Results:

Significant improvement was detected in ADHD symptomathology, (Baseline vs. endpoint: ADHD-RS : 33.1±6.8 vs. 19.9±6.8, t=6.875, df=11, p=0.0001). A decline in the severity of nicotine dependence, as assessed by FTND (baseline vs. endpoint: 4.1±2.6 vs. 2.0±1.9, t = 4.056, df=11, p= 0.0019), was observed. No significant correlation was found between changes in the ADHD-RS and the FTND following methylphenidate treatment (r=0.09935, p=0.7587).

Conclusion:

Methylphenidate may attenuate smoking behavior in ADHD/BPD female adolescent smokers.

Type
S19-02
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.